Retaglutide is a novel GLP-1 receptor agonist currently under research for the treatment of metabolic disorders. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://abelmddt863164.blogscribble.com/39220916/retaglutide-a-promising-glp-1-receptor-agonist